首頁 > 市場調查報告書 > 醫療設備

市場調查報告書

商品編碼

1434036

細胞冷凍保存市場-按產品類型（冷凍保護劑、設備）、細胞類型（幹細胞、卵母細胞和胚胎細胞、精子細胞）、應用（藥物發現與開發、再生醫學）、最終用途-全球預測，2024 -2032

Cell Cryopreservation Market-By Product Type (Cryoprotectant Agents, Equipment), Cell Type (Stem Cells, Oocytes & Embryotic Cells, Sperm Cells), Application (Drug Discovery & Development, Regenerative Medicine), End-use-Global Forecast, 2024-2032

出版日期: 2024年01月15日 | 出版商:

Global Market Insights Inc. | 英文 185 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

由於生物樣本庫技術的進步和幹細胞研究應用的不斷擴大，全球細胞冷凍保存市場從 2024 年到 2032 年的CAGR將達到 21.5%。隨著新實驗室的成立，用於各種目的（例如再生醫學、藥物發現和組織工程）的冷凍細胞的能力增加。這些發展為保存寶貴的細胞資源提供了機會，從而推動了需求。此外，對個人化醫療的日益重視和幹細胞療法的日益採用將進一步促進市場擴張。

例如，2023 年 10 月，專注於細胞和免疫療法解決方案的合約技術開發和製造組織 (CTDMO) OrganaBio 推出了一個名為細胞處理和冷凍保存 (CPC) 服務的新部門。該專業部門旨在提供分散的臨床試驗支持，包括根據行業需求量身定做的快速樣本處理和資料收集。

細胞冷凍保存市場根據細胞類型、應用和區域進行分類。

由於對輔助生殖技術 (ART) 和生育力保存程序的需求不斷成長，到 2032 年，卵母細胞和胚胎細胞部分將佔據顯著佔有率。卵母細胞和胚胎細胞對於體外受精 (IVF) 程序和幹細胞研究至關重要，可提高採用率。此外，冷凍保存技術的進步提高了儲存這些細胞的可行性和成功率，進一步推動了這個市場的成長。

在冷凍保存細胞在再生療法、組織工程和幹細胞研究中的應用不斷增加的推動下，到 2032 年，再生醫學領域將獲得顯著的市場佔有率。此外，冷凍保存技術的進步，以及再生醫學研究投資的不斷成長，也促進了該領域的成長。隨著再生醫學成為治療各種疾病的有前景的領域，對冷凍細胞的需求將激增，鞏固該領域的市場領先地位。

亞太細胞冷凍保存產業從 2024 年到 2032 年將呈現顯著的複合CAGR，這歸因於多種因素，包括慢性病盛行率的增加、醫療保健支出的增加以及對幹細胞治療益處的認知不斷提高。此外，該地區不斷擴大的生物技術和製藥產業，加上政府的支持性舉措，將有助於市場成長。憑藉龐大的人口基數和不斷改善的醫療基礎設施，亞太地區將保持其在細胞冷凍保存市場的主導地位。

產業生態系統分析
技術景觀
監管環境
產業影響力
- 成長動力
  - 幹細胞研究興起
  - 增加器官移植手術
  - 個性化醫療的成長趨勢
  - 增加生物樣本庫活動
- 產業陷阱與挑戰
  - 冷凍保存技術成本高
  - 道德和監管挑戰
成長潛力分析
波特的分析
PESTEL分析

第 4 章：競爭格局

介紹
公司市佔率分析
主要市場參與者的競爭分析
競爭定位矩陣
戰略展望矩陣

第 5 章：細胞冷凍保存市場規模與預測：依產品類型，2018-2032

主要動向：依產品類型
冷凍保護劑
- 二甲亞碸 (DMSO)
- 乙二醇
- 甘油
- 其他代理
裝置
- 冰櫃
- 孵化器
- 液態氮供應罐
- 超低溫保存耗材

第 6 章：細胞冷凍保存市場規模與預測：按細胞類型，2018-2032 年

主要動向：依細胞類型
幹細胞
卵母細胞和胚胎細胞
精子細胞
肝細胞
其他細胞類型

第 7 章：細胞冷凍保存市場規模與預測：按應用，2018-2032

主要動向：按應用
藥物發現與開發
再生醫學
器官移植
臨床研究
其他應用

第 8 章：細胞冷凍保存市場規模與預測：依最終用途，2018-2032 年

主要動向：依最終用途
醫院和診所
生物技術和製藥公司
研究和學術機構
合約研究組織 (CRO)

第 9 章：細胞冷凍保存市場規模及預測：按地區分類，2018-2032 年

主要動向：按地區
北美洲
- 美國
- 加拿大
歐洲
- 德國
- 英國
- 法國
- 義大利
- 西班牙
- 歐洲其他地區
亞太地區
- 中國
- 日本
- 印度
- 澳洲
- 韓國
- 亞太地區其他地區
拉丁美洲
- 巴西
- 墨西哥
- 阿根廷
- 拉丁美洲其他地區
中東和非洲
- 沙烏地阿拉伯
- 南非
- 阿拉伯聯合大公國
- 中東和非洲其他地區

第 10 章：公司簡介

Thermo Fisher Scientific Inc.
Sartorius AG
PromoCell GmbH
BioLife Solutions Inc.
Merck KGaA
HiMedia Laboratories
Creative Biolabs
Corning Incorporated
GE Healthcare
Danaher Corporation

簡介目錄

Product Code: 7882

Global Cell Cryopreservation Market will register a 21.5% CAGR from 2024 to 2032 due to advancements in biobanking technologies and the expanding applications of stem cell research. With the launch of new laboratories, there's an increased capacity for cryopreserving cells for various purposes, such as regenerative medicine, drug discovery, and tissue engineering. These developments offer opportunities for preserving valuable cell resources, driving demand. Additionally, the growing emphasis on personalized medicine and the rising adoption of stem cell-based therapies will further contribute to the market expansion.

For instance, in October 2023, OrganaBio, a contract technology development and manufacturing organization (CTDMO) focusing on cell and immunotherapy solutions, introduced a new division called Cell Processing and Cryopreservation (CPC) Services. This specialized division aims to offer decentralized clinical trial support, encompassing prompt sample processing and data capture tailored to the needs of the industry.

The cell cryopreservation market is classified based on cell type, application, and region.

The oocytes and embryotic cells segment will capture a remarkable share by 2032, driven by the increasing demand for assisted reproductive technologies (ART) and fertility preservation procedures. Oocytes and embryotic cells are crucial for in vitro fertilization (IVF) procedures and stem cell research, prompting higher adoption rates. Moreover, advancements in cryopreservation techniques have improved the viability and success rates of storing these cells, further fueling the growth of this segment in the market.

The regenerative medicine segment will achieve notable market share by 2032, fueled by the increasing applications of cryopreserved cells in regenerative therapies, tissue engineering, and stem cell research. Additionally, advancements in cryopreservation techniques, in line with growing investments in regenerative medicine research, bolster the segment's growth. With regenerative medicine emerging as a promising field for treating various medical conditions, the demand for cryopreserved cells will surge, solidifying the segment's leading position in the market.

Asia Pacific cell cryopreservation industry will demonstrate a significant CAGR from 2024 to 2032, attributed to several factors, including the increasing prevalence of chronic diseases, rising healthcare expenditure, and growing awareness about the benefits of stem cell therapy. Moreover, the region's expanding biotechnology and pharmaceutical industries, in tandem with supportive government initiatives, will contribute to market growth. With a large population base and improving healthcare infrastructure, Asia Pacific will maintain its prominence in the cell cryopreservation market.

Chapter 1 Methodology and Scope

1.1 Market scope and definition
1.2 Base estimates and workings
1.3 Forecast calculations
1.4 Data sources
- 1.4.1 Primary
- 1.4.2 Secondary
  - 1.4.2.1 Paid sources
  - 1.4.2.2 Unpaid sources

Chapter 2 Executive Summary

2.1 Global cell cryopreservation market 360 degree synopsis, 2018 - 2032
- 2.1.1 Regional trends
- 2.1.2 Product type trends
- 2.1.3 Cell type trends
- 2.1.4 Application trends
- 2.1.5 End-use trends

Chapter 3 Cell Cryopreservation Industry Insights

3.1 Industry ecosystem analysis
3.2 Technology landscape
3.3 Regulatory landscape
3.4 Industry impact forces
- 3.4.1 Growth drivers
  - 3.4.1.1 Rising stem cell research
  - 3.4.1.2 Increasing organ transplantation procedures
  - 3.4.1.3 Growing trend towards personalized medicine
  - 3.4.1.4 Increasing biobanking activities
- 3.4.2 Industry pitfalls and challenges
  - 3.4.2.1 High cost of cryopreservation technologies
  - 3.4.2.2 Ethical and regulatory challenges
3.5 Growth potential analysis
- 3.5.1 By product type
- 3.5.2 By cell type
- 3.5.3 By application
- 3.5.4 By end-use
3.6 Porter's analysis
3.7 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

4.1 Introduction
4.2 Company market share analysis, 2023
4.3 Competitive analysis of major market players, 2023
4.4 Competitive positioning matrix, 2023
4.5 Strategic outlook matrix, 2023

Chapter 5 Cell Cryopreservation Market Size and Forecast, By Product Type, 2018-2032 (USD Million)

5.1 Key trends, by product type
5.2 Cryoprotectant agents
- 5.2.1 Dimethyl sulfoxide (DMSO)
- 5.2.2 Ethylene glycol
- 5.2.3 Glycerol
- 5.2.4 Other agents
5.3 Equipment
- 5.3.1 Freezers
- 5.3.2 Incubators
- 5.3.3 Liquid nitrogen supply tanks
- 5.3.4 Cryopreservation consumables

Chapter 6 Cell Cryopreservation Market Size and Forecast, By Cell Type, 2018-2032 (USD Million)

6.1 Key trends, by cell type
6.2 Stem cells
6.3 Oocytes and embryotic cells
6.4 Sperm cells
6.5 Hepatocytes
6.6 Other cell types

Chapter 7 Cell Cryopreservation Market Size and Forecast, By Application, 2018-2032 (USD Million)

7.1 Key trends, by application
7.2 Drug discovery and development
7.3 Regenerative medicine
7.4 Organ transplantation
7.5 Clinical research
7.6 Other applications

Chapter 8 Cell Cryopreservation Market Size and Forecast, By End-use, 2018-2032 (USD Million)

8.1 Key trends, by end-use
8.2 Hospitals and clinics
8.3 Biotechnology and pharmaceutical companies
8.4 Research and academic institutes
8.5 Contract research organizations (CROs)

Chapter 9 Cell Cryopreservation Market Size and Forecast, By Region, 2018-2032 (USD Million)

9.1 Key trends, by region
9.2 North America
- 9.2.1 U.S.
- 9.2.2 Canada
9.3 Europe
- 9.3.1 Germany
- 9.3.2 UK
- 9.3.3 France
- 9.3.4 Italy
- 9.3.5 Spain
- 9.3.6 Rest of Europe
9.4 Asia Pacific
- 9.4.1 China
- 9.4.2 Japan
- 9.4.3 India
- 9.4.4 Australia
- 9.4.5 South Korea
- 9.4.6 Rest of Asia Pacific
9.5 Latin America
- 9.5.1 Brazil
- 9.5.2 Mexico
- 9.5.3 Argentina
- 9.5.4 Rest of Latin America
9.6 Middle East and Africa
- 9.6.1 Saudi Arabia
- 9.6.2 South Africa
- 9.6.3 UAE
- 9.6.4 Rest of Middle East and Africa